AxoGen Total Assets 2010-2025 | AXGN
AxoGen total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
| AxoGen Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $204 |
| 2023 | $197 |
| 2022 | $195 |
| 2021 | $208 |
| 2020 | $201 |
| 2019 | $155 |
| 2018 | $160 |
| 2017 | $59 |
| 2016 | $46 |
| 2015 | $37 |
| 2014 | $16 |
| 2013 | $28 |
| 2012 | $20 |
| 2011 | $12 |
| 2010 | $6 |
| 2009 | $17 |
| AxoGen Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-06-30 | $205 |
| 2025-03-31 | $196 |
| 2024-12-31 | $204 |
| 2024-09-30 | $192 |
| 2024-06-30 | $189 |
| 2024-03-31 | $187 |
| 2023-12-31 | $197 |
| 2023-09-30 | $195 |
| 2023-06-30 | $192 |
| 2023-03-31 | $189 |
| 2022-12-31 | $195 |
| 2022-09-30 | $196 |
| 2022-06-30 | $196 |
| 2022-03-31 | $198 |
| 2021-12-31 | $208 |
| 2021-09-30 | $210 |
| 2021-06-30 | $211 |
| 2021-03-31 | $197 |
| 2020-12-31 | $201 |
| 2020-09-30 | $194 |
| 2020-06-30 | $170 |
| 2020-03-31 | $145 |
| 2019-12-31 | $155 |
| 2019-09-30 | $154 |
| 2019-06-30 | $157 |
| 2019-03-31 | $160 |
| 2018-12-31 | $160 |
| 2018-09-30 | $162 |
| 2018-06-30 | $161 |
| 2018-03-31 | $55 |
| 2017-12-31 | $59 |
| 2017-09-30 | $42 |
| 2017-06-30 | $43 |
| 2017-03-31 | $43 |
| 2016-12-31 | $46 |
| 2016-09-30 | $31 |
| 2016-06-30 | $32 |
| 2016-03-31 | $33 |
| 2015-12-31 | $37 |
| 2015-09-30 | $41 |
| 2015-06-30 | $25 |
| 2015-03-31 | $28 |
| 2014-12-31 | $16 |
| 2014-09-30 | $20 |
| 2014-06-30 | $22 |
| 2014-03-31 | $25 |
| 2013-12-31 | $28 |
| 2013-09-30 | $30 |
| 2013-06-30 | $16 |
| 2013-03-31 | $18 |
| 2012-12-31 | $20 |
| 2012-09-30 | $10 |
| 2012-06-30 | $10 |
| 2012-03-31 | $10 |
| 2011-12-31 | $12 |
| 2011-09-30 | $14 |
| 2011-06-30 | $12 |
| 2011-03-31 | $11 |
| 2010-12-31 | $6 |
| 2010-09-30 | $10 |
| 2010-06-30 | $11 |
| 2010-03-31 | $11 |
| 2009-12-31 | $17 |
| 2009-09-30 | $0 |
| 2009-06-30 | $1 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.716B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $186.846B | 22.60 |
| Intuitive Surgical (ISRG) | United States | $172.230B | 71.39 |
| IDEXX Laboratories (IDXX) | United States | $51.191B | 53.28 |
| Edwards Lifesciences (EW) | United States | $47.784B | 31.67 |
| Alcon (ALC) | Switzerland | $39.973B | 26.83 |
| IQVIA Holdings (IQV) | United States | $32.647B | 18.45 |
| DexCom (DXCM) | United States | $32.027B | 48.04 |
| Mettler-Toledo (MTD) | United States | $27.126B | 32.20 |
| STERIS (STE) | Ireland | $24.578B | 26.16 |
| Waters (WAT) | United States | $17.663B | 24.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.277B | 0.00 |
| Hologic (HOLX) | United States | $15.294B | 16.57 |
| Penumbra (PEN) | United States | $9.973B | 72.86 |
| Sysmex ADR (SSMXY) | Japan | $8.372B | 26.60 |
| Globus Medical (GMED) | United States | $8.202B | 18.92 |
| Masimo (MASI) | United States | $7.912B | 26.63 |
| Teleflex (TFX) | United States | $5.553B | 8.96 |
| Glaukos (GKOS) | United States | $5.215B | 0.00 |
| TransMedics (TMDX) | United States | $4.155B | 63.15 |
| Integer Holdings (ITGR) | United States | $3.759B | 18.76 |
| LivaNova (LIVN) | United Kingdom | $2.915B | 16.68 |
| Alphatec Holdings (ATEC) | United States | $2.351B | 0.00 |
| Veracyte (VCYT) | United States | $2.320B | 32.05 |
| PROCEPT BioRobotics (PRCT) | United States | $2.191B | 0.00 |
| Artivion (AORT) | United States | $2.030B | 102.43 |
| Nihon Kohden (NHNKY) | Japan | $1.894B | 22.61 |
| Elekta AB (EKTAY) | Sweden | $1.854B | 17.34 |
| Integra LifeSciences Holdings (IART) | United States | $1.111B | 6.37 |
| OPKO Health (OPK) | United States | $1.103B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.073B | 0.00 |
| IRadimed (IRMD) | United States | $0.888B | 43.10 |
| Tandem Diabetes Care (TNDM) | United States | $0.722B | 0.00 |
| SiBone (SIBN) | United States | $0.670B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.665B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.574B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.527B | 9.31 |
| OrthoPediatrics (KIDS) | United States | $0.488B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.462B | 3.71 |
| Treace Medical Concepts (TMCI) | United States | $0.451B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.381B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.379B | 9.63 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.361B | 86.08 |
| RxSight (RXST) | United States | $0.346B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.286B | 19.72 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.234B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.223B | 0.00 |
| Neuronetics (STIM) | United States | $0.220B | 0.00 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| Inogen (INGN) | United States | $0.199B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Accuray (ARAY) | United States | $0.170B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.150B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.128B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.112B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.109B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.095B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.073B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 23.33 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.027B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.023B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Vyome Holdings (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.33 |